← Back to Search

Behavioral Intervention

Arm II (ASCENT intervention) for Blood Cancers

N/A

Recruiting

Led By Andrea L. Cheville, M.D.

Research Sponsored by Mayo Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age >= 18

Pain that developed or worsened following cancer diagnosis

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3 months, 6 months

Awards & highlights

Study Summary

This trial is testing a new pain management program called ASCENT for cancer survivors who live in rural areas or identify as Hispanic. Cancer pain is a big problem that often goes untreated and causes a lot of

Who is the study for?

This trial is for rural and Hispanic cancer survivors experiencing pain from conditions like blood cancers and tumors. It's designed to help those who may struggle with managing their pain, including issues with opioid use. Participants should be comfortable using digital tools for health monitoring.Check my eligibility

What is being tested?

The ASCENT intervention being tested includes an educational guide on cancer pain management, personalized coaching by community health workers, and oversight by pain care managers. The study uses electronic records to tailor the approach to each patient's needs.See study design

What are the potential side effects?

Since this trial focuses on education and personalized coaching rather than medication or invasive procedures, there are minimal physical side effects expected. However, participants might experience emotional or psychological stress while discussing pain management.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

My pain started or got worse after my cancer diagnosis.

Select...

I was diagnosed with cancer and have been to a Mayo clinic in the last 15 years.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3 months, 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3 months, 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months, 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Pain Score

Secondary outcome measures

Adherence to behavioral multimodal pain care plan components

Anxiety

Depression

+8 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm II (ASCENT intervention)Experimental Treatment6 Interventions

Patients receive the ASCENT guide and attend 3 video or phone calls over 30 minutes each with their CHW and/or PCM. During the first call, patients discuss barriers to receiving help for their pain with their CHW. During the second call, patients work with their PCM to develop an action plan for addressing their pain using the different techniques and interventions detailed in the ASCENT guide. During the third and final call, patients meet with both their CHW and PCM to discuss specialist recommendations for their pain management plan. After the final visit, patients will be contacted by the CHW or PCM every other week to monitor their progress and may also be contacted as-needed based on the their reported pain intensity, symptoms, or reported barriers.

Group II: Arm I (enhanced usual care)Active Control4 Interventions

Patients receive enhanced usual care, which includes access to the educational and pain self-management materials developed for the ASCENT trial (the ASCENT guide).

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Health Telemonitoring

2013

N/A

~120

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor

3,213 Previous Clinical Trials

3,766,351 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,669 Previous Clinical Trials

40,925,661 Total Patients Enrolled

1 Trials studying Blood Cancers

70 Patients Enrolled for Blood Cancers

Andrea L. Cheville, M.D.Principal InvestigatorMayo Clinic in Rochester

1 Previous Clinical Trials

140 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research study currently accepting new participants?

"Apologies for the confusion. According to the information available on clinicaltrials.gov, this specific trial is not currently seeking participants. The initial posting date was January 1st, 2024 and it was last updated on December 27th, 2023. However, please note that there are currently a total of 2524 other ongoing studies actively recruiting participants at this time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Collaborative Pain Management Intervention for Improving Cancer Pain Management in Rural and Hispanic Cancer Survivors

2024. "A Collaborative Pain Management Intervention for Improving Cancer Pain Management in Rural and Hispanic Cancer Survivors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06198010.

All > Phoenix > Paid Studies Minneapolis